These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38675826)

  • 1. COVID-19 Vaccine Hesitancy and Associated Oral Cholera Vaccine Hesitancy in a Cholera-Endemic Country: A Community-Based Cross-Sectional Study in the Democratic Republic of Congo.
    Nyalundja AD; Bugeme PM; Ntaboba AB; Hatu'm VU; Ashuza GS; Tamuzi JL; Ndwandwe D; Iwu-Jaja C; Wiysonge CS; Katoto PDMC
    Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N; Schaetti C; Merten S; Schindler C; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2016 Jan; 16():36. PubMed ID: 26762151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
    Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
    BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.
    Merten S; Schaetti C; Manianga C; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2013 Jan; 13():60. PubMed ID: 23339647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan.
    Peprah D; Palmer JJ; Rubin GJ; Abubakar A; Costa A; Martin S; Perea W; Larson HJ
    Vaccine; 2016 Jul; 34(33):3823-7. PubMed ID: 27265459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
    Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
    BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
    Kasting ML; Macy JT; Grannis SJ; Wiensch AJ; Lavista Ferres JM; Dixon BE
    JMIR Public Health Surveill; 2022 Nov; 8(11):e37203. PubMed ID: 36219842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-Saharan Africa.
    Abubakari SW; Workneh F; Asante KP; Hemler EC; Madzorera I; Wang D; Ismail A; Assefa N; Azemraw T; Lankoande B; Nuhu AR; Chukwu A; Mapendo F; Millogo O; Olufemi AA; Okpara D; Boudo V; Mwanyika-Sando M; Berhane Y; Baernighausen T; Oduola A; Vuai S; Sie A; Soura A; Killewo J; Tajudeen R; Fawzi WW; Smith ER
    PLOS Glob Public Health; 2023; 3(7):e0000713. PubMed ID: 37450441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
    Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
    JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.
    Massing LA; Aboubakar S; Blake A; Page AL; Cohuet S; Ngandwe A; Mukomena Sompwe E; Ramazani R; Allheimen M; Levaillant P; Lechevalier P; Kashimi M; de la Motte A; Calmejane A; Bouhenia M; Dabire E; Bompangue D; Kebela B; Porten K; Luquero F
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006369. PubMed ID: 29734337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccine Coverage and Factors Associated with Vaccine Hesitancy: A Cross-Sectional Survey in the City of Kinshasa, Democratic Republic of Congo.
    Akilimali PZ; Egbende L; Kayembe DM; Kabasubabo F; Kazenza B; Botomba S; Tran NT; Mashinda DK
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.
    Barrall AL; Hoff NA; Nkamba DM; Musene K; Ida N; Bratcher A; Dzogang C; Tangney S; Beia M; Nzaji MK; Kampilu D; Mbaka Onya G; Luhata C; Gadoth A; Musenga EM; Mbala P; Kaba D; Rimoin AW
    Vaccine; 2022 Aug; 40(34):4998-5009. PubMed ID: 35840471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Trustworthiness, Health Literacy, and Self-Efficacy in Communicating With COVID-19 Vaccine-Hesitant Audiences: Web-Based Survey Study.
    Weerakoon SM; Henson-Garcia M; Valerio-Shewmaker MA; Messiah SE; Knell G
    JMIR Form Res; 2022 Aug; 6(8):e38076. PubMed ID: 35878123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental COVID-19 Vaccine Hesitancy in the United States.
    Ruiz JB; Bell RA
    Public Health Rep; 2022; 137(6):1162-1169. PubMed ID: 35915993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    Joshi A; Surapaneni KM; Kaur M; Bhatt A; Nash D; El-Mohandes A
    PLoS One; 2022; 17(6):e0269299. PubMed ID: 35679313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographic predictors of COVID-19 vaccine hesitancy and leading concerns with COVID-19 vaccines among pregnant women at a South Texas clinic.
    Sutanto MY; Hosek MG; Stumpff SK; Neuhoff BK; Hernandez BS; Wang Z; Ramsey PS; Boyd AR
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10368-10374. PubMed ID: 36195447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.